Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-11-10

Clinical Trial Update: Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2. [NA]

View source ↗

Summary

A completed study investigating calcitonin gene-related peptide-induced headache in patients with familial hemiplegic migraine type 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcitonin gene-related peptide (calcitonin gene-related peptide)

Snippet

Sponsor: Danish Headache Center | Conditions: Familial Hemiplegic Migraine | NA | Status: COMPLETED